Pharmacovigilance of antimalarial treatment in Uganda: community perceptions and suggestions for reporting adverse events.

Pharmacovigilance of antimalarial treatment in Uganda: community perceptions and suggestions for reporting adverse events.

Item
http://www.wikidata.org/entity/Q38875987
Repeated treatment of recurrent uncomplicated Plasmodium falciparum malaria in Senegal with fixed-dose artesunate plus amodiaquine versus fixed-dose artemether plus lumefantrine: a randomized, open-label trialDesigning adverse event forms for real-world reporting: participatory research in UgandaRecognition and reporting of suspected adverse drug reactions by surveyed healthcare professionals in Uganda: key determinantsExperience of safety monitoring in the context of a prospective observational study of artemether-lumefantrine in rural Tanzania: lessons learned for pharmacovigilance reporting.Increased risk of early vomiting among infants and young children treated with dihydroartemisinin-piperaquine compared with artemether-lumefantrine for uncomplicated malaria.Evaluation and pharmacovigilance of projects promoting cultivation and local use of Artemisia annua for malaria.Pharmacovigilance for antiretroviral drugs in Africa: lessons from a study in Abidjan, Cote d'Ivoire.Improving access to health care for malaria in Africa: a review of literature on what attracts patients.Knowledge and barriers related to reporting of acute transfusion reactions among healthcare workers in Namibia.Anti-malarial drug safety information obtained through routine monitoring in a rural district of South-Western SenegalAdverse drug reaction reporting among health care workers at Mulago National Referral and Teaching hospital in Uganda.Development of a pharmacovigilance safety monitoring tool for the rollout of single low-dose primaquine and artemether-lumefantrine to treat Plasmodium falciparum infections in Swaziland: a pilot study.Factors affecting patient reporting of adverse drug reactions: a systematic review.Establishing pharmacovigilance programs in resource-limited settings: the example of treating malaria.Improving access to health care for malaria in Africa: a review of literature on what attracts patients
P2860

Pharmacovigilance of antimalarial treatment in Uganda: community perceptions and suggestions for reporting adverse events.

Item
http://www.wikidata.org/entity/Q38875987
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Pharmacovigilance of antimalar ...... for reporting adverse events.
@en
type
label
Pharmacovigilance of antimalar ...... for reporting adverse events.
@en
prefLabel
Pharmacovigilance of antimalar ...... for reporting adverse events.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P921
P356
P1433
P1476
Pharmacovigilance of antimalar ...... for reporting adverse events.
@en
P2093
P2860
P304
P31
P356
10.1111/J.1365-3156.2008.02119.X
P433
P478
P50
P577
P5875
P698
P921